SAVE-Care Consortium
SGLT2i As Novel Gout Care
Our Vision
The vision of the SAVE-Care Consortium is to generate evidence for the potential use of SGLT2i as a part of a comprehensive gout and cardiometabolic comorbidity treatment plan.
SGLT2i As Novel Gout Care
The vision of the SAVE-Care Consortium is to generate evidence for the potential use of SGLT2i as a part of a comprehensive gout and cardiometabolic comorbidity treatment plan.